These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 24813390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
    Tariq M, Alam MA, Singh AT, Iqbal Z, Panda AK, Talegaonkar S.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():448-456. PubMed ID: 25769281
    [Abstract] [Full Text] [Related]

  • 8. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176
    [Abstract] [Full Text] [Related]

  • 9. CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.
    Gao DY, Lin TsT, Sung YC, Liu YC, Chiang WH, Chang CC, Liu JY, Chen Y.
    Biomaterials; 2015 Oct 01; 67():194-203. PubMed ID: 26218745
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immuno-modulatory and cellular antioxidant activities of κ-selenocarrageenan in combination with Epirubicin in H22 hepatoma-bearing mice.
    Ling N, Zhou X, Ji Y, Li W, Ji C, Qi Z.
    Biomed Pharmacother; 2017 Jul 01; 91():132-137. PubMed ID: 28448867
    [Abstract] [Full Text] [Related]

  • 12. UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma.
    Dong H, Yang X, Xie J, Xiang L, Li Y, Ou M, Chi T, Liu Z, Yu S, Gao Y, Chen J, Shao J, Jia L.
    Biochem Pharmacol; 2015 Jan 15; 93(2):151-62. PubMed ID: 25522955
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X, Li J, Yan M.
    Drug Dev Ind Pharm; 2016 Oct 15; 42(10):1590-9. PubMed ID: 26942448
    [Abstract] [Full Text] [Related]

  • 15. A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity.
    Yuan A, Wu J, Song C, Tang X, Qiao Q, Zhao L, Gong G, Hu Y.
    J Pharm Sci; 2013 May 15; 102(5):1626-35. PubMed ID: 23423631
    [Abstract] [Full Text] [Related]

  • 16. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Abo Mansour HE, El-Batsh MM, Badawy NS, Mehanna ET, Mesbah NM, Abo-Elmatty DM.
    Hum Exp Toxicol; 2020 Nov 15; 39(11):1528-1544. PubMed ID: 32519553
    [Abstract] [Full Text] [Related]

  • 17. Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma.
    Zhang C, An T, Wang D, Wan G, Zhang M, Wang H, Zhang S, Li R, Yang X, Wang Y.
    J Control Release; 2016 Mar 28; 226():193-204. PubMed ID: 26896737
    [Abstract] [Full Text] [Related]

  • 18. Progesterone augments epirubicin-induced apoptosis in HA22T/VGH cells by increasing oxidative stress and upregulating Fas/FasL.
    Chang WT, Hsieh BS, Cheng HL, Lee KT, Chang KL.
    J Surg Res; 2014 May 15; 188(2):432-41. PubMed ID: 24594218
    [Abstract] [Full Text] [Related]

  • 19. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
    Chu Q, Xu H, Gao M, Guan X, Liu H, Deng S, Huo X, Liu K, Tian Y, Ma X.
    Int J Nanomedicine; 2016 May 15; 11():449-63. PubMed ID: 26869788
    [Abstract] [Full Text] [Related]

  • 20. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A, Nayak D, Srinivas M, Kumar A, Khare V, Katoch A, Goswami A, Vishwakarma RA, Sawant SD, Gupta PN.
    Eur J Pharm Sci; 2017 Jan 15; 97():79-91. PubMed ID: 27989859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.